Abstract

Microphthalmia, anophthalmia, and ocular coloboma, collectively considered together under the acronym MAC, represent a vast clinical spectrum that is a common cause of childhood visual impairment. MAC conditions carry a profound lifelong impact for both child and family, with significant social, emotional, and health implications including elevated early mortality rates in syndromic cases. Most MAC cases are sporadic; around two-thirds are syndromic with up to one-third displaying craniofacial anomalies. Inheritance can be autosomal or X-linked, and in both cases, it can be either dominant or recessive. The occurrence of de novo mutations, mosaicism and incomplete penetrance makes clinical prediction of inheritance patterns challenging. This group of conditions is highly genetically heterogenous with over 90 disease-causing genes already identified. Genomic testing of MAC patients using high-throughput sequencing is increasingly successful in identifying the underlying cause. Given that de novo mutations are common in apparently sporadic cases (i.e. the majority of individuals with MAC), testing of parent-offspring trios is the most effective strategy in this group of patients.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.